A Randomized Phase II Trial To Evaluate The Efficacy And Safety Of Vandetanib (ZD6474, ZACTIMA ™) Versus Vinorelbine In Patients With Inoperable Or Relapsed Malignant Mesothelioma.
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007708/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A clinical study to assess if a new investigational drug is effective in treating malignant
mesothelioma, compared to a chemotherapy treatment (Navelbine®). In this study the patients
will be assigned by chance to receive either the new drug or a chemotherapy treatment
(Navelbine®). Treatment will continue as long as the cancer does not worsen and the patient
wishes to continue in the study. The study will recruit approximately 66 patients.
提供机构：
Vivli
创建时间：
2022-02-10
